Search - tctmd.com

Displaying 681 - 700 of 716

Sort: Relevancy | Date

News Daily News

STEMI Patients Benefit From Clopidogrel Given Prior to PCI Center

Caitlin E. Cox

September 28, 2011

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Daily News

Antiplatelet Therapy Plus SSRI Spurs Bleeding After MI

Yael L. Maxwell

September 26, 2011

News Daily News

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

September 21, 2011

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Daily News

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

L.A. McKeown

September 13, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

September 02, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Daily News

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

L.A. McKeown

August 05, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Daily News

Canada Approves Ticagrelor in ACS Patients

June 02, 2011

News Daily News

NHLBI Stops High-Dose Niacin Trial Early Due to Lack of Efficacy

May 27, 2011

News Daily News

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

Caitlin E. Cox

May 27, 2011

Advertisement

STEMI Patients Benefit From Clopidogrel Given Prior to PCI Center

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Antiplatelet Therapy Plus SSRI Spurs Bleeding After MI

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

ESC Congress 2011: Drugs, Devices Work Together

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Long-term Antiplatelet Therapy: All Risk, No Benefit

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Canada Approves Ticagrelor in ACS Patients

NHLBI Stops High-Dose Niacin Trial Early Due to Lack of Efficacy

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content